REFERENCES
- Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004; 23:698–702.
- Yip NH, Yuen G, Lazar EJ, Analysis of hospitalizations for COPD Exacerbation: Opportunities for improving care. COPD 2010; 85–92.
- Stang P, Lydick E, Silberman C, Kempel A, Keating ET. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000; 117(5 Suppl 2):354S–9S.
- Barr RG, Celli BR, Mannino DM, Petty T, Rennard SI, Sciurba FC, Stoller JK, Thomashow BM, Turino GM. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med 2009; 122:348–355.
- Eurich DT, Marrie TJ, Johnstone J, Majumdar SM. Mortality reduction with influenza vaccine in patients with pneumonia outside ‘‘flu’’ season. Am J Respir Crit Care Med 2008; 178:527–533.
- Crim C, Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Willits LR, Yates JC, Vestbo J. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009; 34:641–647.